Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
cancer biology, immunology, precision immunotherapy, or translational biomedical research. Process to Apply: Open Date: 07/10/2026, Closing date: 07/05/2027 at 11:59 PM Eastern Time. Curriculum vitae One
-
immunology, with the aim of developing improved cell-based immunotherapies for the treatment of cancer. Our research focuses on rationally harnessing and programming the immune system’s ability to perform
-
. Major research priorities include Immunology, Cell and Immunotherapy, and Neurosciences. We are seeking an outstanding and highly motivated Postdoctoral Researcher to join our internationally active
-
immunotherapy for blood cancers. Our laboratory is broadly interested in the mechanisms by which synthetic receptors, such as chimeric antigen receptors (CARs), regulate effective and dysfunctional T cell
-
For disease Interception) (https://www.edent1fi.eu ). The research fellow is sought to support the UK component which is linked to the existing T1D screening program scaled up nationally by the Department
-
agencies, investors, pharma companies etc. This role may also provide the opportunity to join a spin-out company as part of the founding team. Learn more about the innovative work here: https
-
future health axis places a strong emphasis on the development of innovative therapies, including immunotherapy, applied to various pathologies including cancer. The proposed CPJ project is therefore
-
lab focuses on new immune checkpoint pathways and novel immunotherapies from fundamental discoveries to novel drugs to clinical trials. More information can be found in our lab website (https
-
initiatives in one or more of the following areas: Cancer immunoprevention Cancer immunotherapy Biomarker discovery and validation Precision oncology Point-of-care diagnostic technologies Multi-omics and
-
. The Duke Cancer Institute’s Phase 1 and Immunotherapy Program (PHIIT) is seeking a highly skilled Clinical Research Nurse Coordinator to join our dynamic Oncology Clinical Research Unit (CRU). In